A recent multi-centric study conducted across five Asian countries (China, India, Indonesia, Pakistan, and Vietnam) that are endemic for typhoid reported the prevalence of multidrug-resistant S. typhi strains ranging from 7% to 65%. 1 Recently, several studies have found that strains previously resistant to the first-line drugs (chloramphenicol, ampicillin and co-trimoxazole) are now showing decreasing resistance. [2] [3] [4] The withdrawal of selective pressure has probably resulted in the reemergence of sensitivity to these first-line drugs. A study done by Gupta et al found a very high sensitivity of 93.2%, 86.2% and 71.3% with chloramphenicol, cotrimoxazole and ampicillin, respectively. 2 Similarly, a reemergence of chloramphenicol sensitivity was reported by Prajapati et al. Multi drug resistance trend was evaluated from the data of a prospective cross sectional study conducted at Kanchi Kamakoti Childs Trust hospital from 2013-2014 by comparing the previous studies with our study. In a
